FDA Approves Stem Cell Trial for Macular Degeneration

Advanced Cell Technology said on Monday it had won U.S. Food and Drug Administration approval to test human embryonic stem cells for treating macular degeneration, a common cause of vision loss.
Reuters Health Information

Full Story →